SCHEMBL4010819

SCHEMBL4010819

CCc1sc(NC(=O)C(C)(C)S(=O)(=O)CC2CCOCC2)nc1-c1ccccc1.Cc1sc(NC(=O)C(C)(C)S(=O)(=O)CC2CCOCC2)nc1-c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.51
MAPT P10636 3/20 0.46
HSD17B10 Q99714 4/20 0.45
HPGD P15428 2/20 0.45
TSHR P16473 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
RORC P51449 2/20 0.45
CNR2 P34972 3/20 0.43
CNR1 P21554 2/20 0.43
ALOX5 P09917 1/20 0.42
MAPK1 P28482 1/20 0.42
GSTO1 P78417 1/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
RAB9A P51151 2/20 0.41
NPC1 O15118 1/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1622016 0.96 ALDH1A1 (0.55) ALDH1A1MAPTHSD17B10HPGDTSHR
SCHEMBL1621629 0.94 CNR2 (0.48) ALDH1A1MAPTHSD17B10HPGDCYP1A2
SCHEMBL4012648 0.85 CNR2 (0.51) ALDH1A1MAPTHSD17B10HPGDTSHR
SCHEMBL16358874 0.79 ALDH1A1 (0.55) ALDH1A1MAPTHSD17B10HPGDTSHR
SCHEMBL1621732 0.78 ALDH1A1 (0.61) ALDH1A1MAPTHSD17B10HPGDTSHR
SCHEMBL1621484 0.78 SMN1; SMN2 (0.57) HSD17B10CNR2CNR1MAPK1MEN1
SCHEMBL1621286 0.78 CNR2 (0.51) ALDH1A1CNR2CNR1MAPK1MEN1
SCHEMBL15219069 0.77 ALDH1A1 (0.48) ALDH1A1MAPTHSD17B10HPGDCYP1A2
SCHEMBL1621081 0.77 GCK (0.57) ALDH1A1MAPTCNR2CNR1MAPK1
SCHEMBL1621250 0.77 ALDH1A1 (0.58) ALDH1A1MAPTHSD17B10HPGDCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2074084-A1 COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR Boehringer Ingelheim International GmbH (DE) 2009-07-01 EP disclosed
WO-2008039645-A1 COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-04-03 WO disclosed